Selank vs Semax: Which Nootropic Peptide Is Better for You?

Selank vs Semax: Two Paths to Cognitive Enhancement

Selank and Semax are both peptide-based nootropics developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Both are approved pharmaceuticals in Russia — Selank for generalized anxiety disorder and Semax for stroke recovery and cognitive disorders. Despite their shared origin and overlapping nootropic reputation, they work through fundamentally different mechanisms and serve different cognitive goals.

Understanding these differences is essential for choosing the right compound. Selank is primarily anxiolytic with secondary cognitive benefits — it calms the mind while sharpening it. Semax is primarily stimulatory and neuroprotective — it activates cognitive performance and upregulates brain-derived neurotrophic factor (BDNF). They can be used independently or combined, but knowing which mechanism you need determines which compound to start with.

If you are new to nootropic peptides, our What Are Peptides? overview provides foundational context. For the broader cognitive peptide landscape including compounds like Dihexa and Cerebrolysin, visit our Cognitive Stack page.

Selank: Mechanism and Profile

Selank is a synthetic analog of the naturally occurring immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg), with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. The addition of the Pro-Gly-Pro tail extends tuftsin's half-life from minutes to hours by conferring resistance to peptidase degradation.

Primary Mechanisms:

• GABAergic Modulation. Selank modulates GABA-A receptor activity, enhancing inhibitory neurotransmission. This is the primary mechanism underlying its anxiolytic effects. Unlike benzodiazepines, which directly bind to GABA-A receptors and cause sedation and dependence, Selank modulates GABA signaling indirectly, producing anxiety reduction without sedation or cognitive impairment.
• Serotonin System. Selank influences serotonin metabolism, affecting the balance between serotonin and its metabolites. Studies show it can stabilize serotonin levels, which contributes to mood regulation and emotional stability. This serotonergic activity differentiates Selank from purely GABAergic anxiolytics.
• Enkephalin Modulation. Selank has been shown to affect enkephalin degradation, potentially modulating the endogenous opioid system. This may contribute to its stress-resilience and mild mood-elevating properties without producing opioid-like euphoria or dependence.
• Gene Expression. Microarray studies have shown that Selank modulates expression of 36 genes involved in GABAergic signaling, neurotransmitter transport, and inflammatory pathways in the hippocampus and frontal cortex. This broad transcriptomic effect suggests mechanisms beyond simple receptor binding.

Clinical Profile:

In Russian clinical practice, Selank is used for generalized anxiety disorder at a standard intranasal dose of 300 mcg three times daily. Clinical trials demonstrated anxiety reduction comparable to phenazepam (a benzodiazepine) without sedation, cognitive impairment, or withdrawal symptoms. Patients maintained normal reaction times and cognitive function while experiencing significant anxiety reduction.

Semax: Mechanism and Profile

Semax is a synthetic analog of ACTH (adrenocorticotropic hormone) fragment 4-10, with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Like Selank, the Pro-Gly-Pro extension enhances metabolic stability. Despite being derived from ACTH, Semax does not stimulate cortisol production — the corticotropic activity resides in ACTH fragments 1-3, not 4-10.

Primary Mechanisms:

• BDNF Upregulation. This is Semax's most significant mechanism. Semax robustly increases brain-derived neurotrophic factor (BDNF) expression in the hippocampus, frontal cortex, and basal forebrain. BDNF is the brain's primary growth factor for neuronal survival, synaptic plasticity, and learning. The BDNF-upregulating effect begins within hours and persists beyond the peptide's plasma half-life.
• NGF and GDNF. Beyond BDNF, Semax also upregulates nerve growth factor (NGF) and glial cell line-derived neurotrophic factor (GDNF). This broader neurotrophic profile supports multiple neuronal populations and may contribute to neuroprotection against various insults.
• Dopaminergic Modulation. Semax modulates dopamine and serotonin turnover in the brain, contributing to its cognitive-enhancing and motivation-promoting effects. This dopaminergic activity is likely why users report improved focus, motivation, and cognitive drive.
• Melanocortin Receptors. As an ACTH fragment, Semax interacts with melanocortin receptors (MC3R and MC4R), though with lower affinity than full-length ACTH. This melanocortin signaling contributes to its neurotrophic and anti-inflammatory effects.

Clinical Profile:

In Russia, Semax is approved for acute ischemic stroke recovery, cognitive disorders of vascular origin, and optic nerve atrophy. The stroke indication reflects Semax's potent neuroprotective properties — clinical trials demonstrated improved neurological outcomes when Semax was administered during acute stroke. For cognitive enhancement, a nasal spray (Semax 0.1%) delivering 200-600 mcg per dose is the standard formulation.

Head-to-Head Comparison

Which One Should You Choose?

The choice between Selank and Semax depends primarily on your cognitive goal and baseline state:

Choose Selank If:

• Anxiety is your primary barrier to cognitive performance
• You need to reduce mental noise, racing thoughts, or social anxiety while maintaining function
• You want cognitive enhancement without stimulation
• You work in high-stress environments where calm under pressure matters
• You are sensitive to stimulants or find them anxiety-provoking
• Your sleep is disrupted by anxiety or stress

Choose Semax If:

• You want direct cognitive enhancement — improved focus, memory, and processing speed
• You do not have significant anxiety (Semax can occasionally increase anxiety in anxious individuals)
• You need a productivity boost for demanding cognitive tasks
• Neuroprotection is a primary goal (BDNF upregulation, neuronal survival)
• You are recovering from neurological injury or cognitive decline
• You respond well to stimulatory compounds like caffeine

Dosage Protocols Compared

For both compounds, intranasal delivery is the most common and convenient route. For general dosing principles, consult our Peptide Dosage Guide. For cycling strategies, see our Peptide Cycle Length Guide.

Stacking Selank and Semax Together

Many users combine Selank and Semax to get the best of both profiles — the anxiolytic calm of Selank with the cognitive activation of Semax. This combination is part of the Cognitive Stack.

How the Stack Works. Selank's GABA modulation tempers any anxiety or overstimulation that Semax's dopaminergic and BDNF effects might produce. Meanwhile, Semax's cognitive activation adds sharpness that Selank alone does not provide. The result is calm, focused cognitive enhancement — mentally sharp without being wired or anxious.

Stacking Protocol.

• Start with one compound alone for 5-7 days to establish your individual response
• Add the second compound at the lower end of its dosing range
• Common approach: Selank 200-300 mcg + Semax 200-300 mcg, both intranasal, 1-2x daily
• If Semax produces any anxiety, increase the Selank dose or reduce the Semax dose
• Same cycle length applies (2-4 weeks on, 2-4 weeks off)

For comprehensive stacking guidance, see our Peptide Stacking Guide.

Side Effects Comparison

Selank Side Effects:

• Generally very well tolerated with minimal side effects
• Mild fatigue or drowsiness at higher doses (uncommon)
• Nasal irritation with intranasal use
• No reported dependence, tolerance, or withdrawal

Semax Side Effects:

• Generally well tolerated at standard doses
• Mild headache (uncommon, usually with initial use)
• Nasal irritation or dryness with intranasal use
• Potential for increased anxiety or irritability in sensitive individuals or at higher doses
• Hair growth stimulation reported by some users (possibly related to melanocortin receptor activity)
• No reported dependence, tolerance, or withdrawal

Both compounds have favorable safety profiles compared to pharmaceutical anxiolytics and stimulants. For detailed side effect information, visit our Peptide Side Effects guide.

Enhanced Versions: N-Acetyl and Adamax

Both Selank and Semax have enhanced variants available:

N-Acetyl Selank Amidate. An acetylated and amidated form of Selank with improved blood-brain barrier penetration and extended duration. Users report stronger effects at lower doses. The N-acetyl modification protects the N-terminus from aminopeptidase degradation while amidation protects the C-terminus.

N-Acetyl Semax Amidate (NASA). The enhanced version of Semax with similar modifications. NASA users report stronger cognitive stimulation, more robust BDNF effects, and longer duration of action compared to standard Semax. The intensity increase means starting at lower doses is advisable.

Adamax (Semax + Adamantane). A modified Semax with an adamantane group attached. The adamantane modification provides additional NMDA receptor modulation, potentially enhancing both neuroprotection and cognitive effects. Adamax is the most potent Semax variant and should be used at the lowest effective dose.

The Bottom Line

Selank and Semax are complementary nootropic peptides that serve different cognitive needs. Selank is the anxiolytic — it reduces anxiety and mental noise while preserving cognitive function, making it ideal for stress-related cognitive impairment, social anxiety, and situations requiring calm under pressure. Semax is the cognitive activator — it directly enhances focus, memory, and processing speed through BDNF upregulation and neurotrophic support, making it ideal for demanding cognitive tasks, neuroprotection, and productivity.

Both have strong clinical evidence from Russian pharmaceutical approval, favorable safety profiles, and no established tolerance or dependence. The combination — Selank for calm plus Semax for sharpness — represents the most popular nootropic peptide stack in the research community. Start with the compound that matches your primary need, establish your response, then consider adding the other if a broader cognitive profile is desired.